Scientific Programme

Please see below for the HIV & Hepatitis in the Americas Scientific Programme 2019!

To view in Spanish, click here

To view in Portugese click here

Thursday 4 April
Friday 5 April
Saturday 6 April

Thursday 4 April

09.00-10.30Latin American Workshop Group
Chairs: Carlos Beltran, Hospital Barros Luco Trudeau, Santiago, Chile
Ernesto Martínez Buitrago, Infectious Diseases, Santiago de Cali, Colombia

09.00-09.30The LAHWS report: 2013–2017
The 5-year report from the Latin American Workshop Group, the LAHWS report, will
provide a clear view of the current direction of the HIV epidemic for the 18 Spanish
spoken Latin American countries as well as the uptake of WHO and national guidelines.
Data for antiretroviral treatment initiation, selection and virologic suppression will
allow accomplishments for the last two UNAIDS 90-90-90 initiatives in the region to be
discussed. This thorough accumulative real-world data in Latin America will allow The
LAHWS Group to conclude with key recommendations to help control and tackle
the epidemic

09.30-10.00Key strategies for Latin American region to curb HIV epidemic, from real world data
to public health policies

10.00-10.30Discussion

10.30-11.00Coffee

11.00-12.30Industry Symposium

12.30-13.30Lunch and Scientific Posters

13.30-13.45Official Opening and Welcome

13.45-14.45Keynote Lectures

13.45-14.15The Safety of Antiretroviral Drugs During the First Trimester of Pregnancy
Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation, Washington, DC, USA

14.15-14.45First-line Therapy in the Region
Pedro Cahn, Fundación Huésped, Buenos Aires, Argentina

14.45-15.00Coffee and Scientific Posters

15.00-15.30HPV in HIV

15.00-15.30Keynote Lecture: State of the Art for Clinicians
Tim Wilkin, Weill Cornell Medicine, New York, NY, USA

15.30-16.30Oral Papers

15.30-16.15Oral Papers

16.15-16.30Panel Discussion

16.30-17.00Coffee and Scientific Posters

17.00-18.30Industry Symposium

18.30-19.15Welcome Reception and Posters

Back to the top of the page

Friday 5 April

09.00-10.30Industry Symposium

10.30-11.00Coffee and Scientific Posters

11.00-12.30On the Path to Ending TB in the Americas
Chair: Monica Thormann, Salvador B. Gautier Hospital, Santo Domingo, Dominican
Republic

11.00-11.30Keynote Lecture: Challenges of TB/HIV in the region
Alicia Piñeirúa‐Menendez, Clinica Especializada Condesa Iztapalapa, Mexico City,
Mexico

11.30-12.00Oral Papers and discussion

12.00-12.30Keynote Lecture: Treatment and Prevention in Adolescents and their
Transition to Adult Care

Allison Agwu, Johns Hopkins Pediatric, Baltimore, MD, USA

12.30-13.30Lunch and Scientific Posters

13.30-14.00Keynote Lecture: The Future of ART and Cure Update
Daniel Kuritzkes, Harvard Medical School and Brigham Women’s Hospital, Boston, MA,
USA

14.00-14.55HIV and Ageing
14.00-14.20Biology
Peter Hunt, University of California San Francisco, San Francisco, CA, USA

14.20-14.40Clinical context, implications and perspectives
Julian Falutz, Division of Geriatrics, Montreal General Hospital, Montreal, Canada

14.40-14.55Discussion

14.55-16.10Hepatitis: Status Update and What’s New?

14.55-15.15Hepatitis B: is cure on the agenda?
Mark Nelson, Imperial College, London, UK

15.15-15.35Non-viral liver disease and HIV/NASH
Mario Pessoa, University of Sao Paulo, Sao Paulo, Brazil

15.35-15.55Hepatitis C eradication: is it for real in this day and age of economic constriction?
Jorge L Santana, University of Puerto Rico School of Medicine, San Juan, Puerto Rico

15.55-16.10Panel Discussion

16.10-16.35CROI 2019 Review
Luis Soto Ramirez, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán,
Mexico City, Mexico

16.35-17.00Coffee and Scientific Posters

17.00-18.00Industry Symposium

18.00-18.45Reception and Scientific Posters

Back to the top of the page

Saturday 6 April

09.00-10.30Challenging Cases in HIV Prevention and Management
In collaboration with the International Antiviral Society-USA (IAS-USA)

09.00-09.30ART sequencing (DTG first-line and DTG second-line)

09.30-10.00Fungal disease, probably crypto
Monica Thormann

10.00-10.30PEP to PrEP
Omar Sued, Fundación Huésped, Buenos Aires, Argentina

10.30-11.00Coffee and Scientific Posters

11.00-12.30Public Health HIV Programs of Latin America and the Caribbean Moving
Beyond NNRTI-based First-line Regimens

Session in collaboration with the Pan American Health Organization (PAHO)

11.00-11.20Landscape of current HIV care and treatment policies and practices

11.20-11.30The role of civil society in the evolving HIV treatment programs: Lessons
learned and recommendations

Javier Hourcade Bellocq, Buenos Aires, Argentina

11.30-11.45ART and sexual and reproductive health of women living with HIV in the Americas:
challenges and opportunities

Rebecca Zash, Reproductive Health, Harvard University Center for AIDS Research,
Cambridge, MA, USA

11.45-12.00The emerging threat of HIV drug resistance: findings to accelerate transition
Santiago Avila-Rios, Center for Research in Infectious Diseases, Mexico City, Mexico

12.00-12.15Experience with dolutegravir in first-line treatment in Brazil: the first 100,000
patients

12.15-12.30Panel Discussion

12.30-13.30Lunch and Scientific Posters

13.30-15.00Barriers and Facilitators to Early Treatment and PrEP Implementation in the Region
In collaboration with the International AIDS Society

13.30-13.55PrEP 2019: Where are we now?
Kenneth Mayer, Boston, MA, USA

13.55-14.05The Brazilian Implementation Plan
Adele Schwartz Benzaken, Brazilian Ministry of Health, Brasilia, Brazil

14.05-14.15From clinical trials to clinical reality: the Peruvian experience
Carlos Cáceres, Cayetano Heredia University, and Institute of Studies in Health,
Sexuality and Human Development, Lima, Peru

14.15-14.25Sexual Health Clinics and PrEP implementation in Buenos Aires
Marcelo Losso, HIV Unit, Hospital Ramos Mejia, Buenos Aires, Argentina

14.25-14.35PrEP implementation in transgender women
Florentino Badial, School of Medicine, Universidad Nacional Autónoma de México,
Mexico City, Mexico

14.35-15.00Discussion

15.00-15.10Closing Remarks and Depart